AtaiBeckley Inc logo

AtaiBeckley Inc

ATAI
Healthcare|Biotechnology|USA
$5.17
-0.16 (-3.00%)
Tangible Book
$0.54

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 1.16, 0.37, 1.36, 24.8, 190.38 ], "ebit_estimate": [ -150.94, -167.48, -174.85, -131.88, -25.13 ], "ebitda_estimate": [ -139.93, -156.67, -169.87, -197.63, -138.93 ], "net_income_estimate": [ -142.15, -166.63, -171.86, -162.26, -77.14 ], "per_share_eps_estimate": [ -0.42, -0.43, -0.41, -0.29, -0.09 ], "eps_nri_estimate": [ -0.38, -0.41, -0.41, -0.4, -0.19 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 0.45, 0.48, 0.35, 0.56, 0.21 ], "pretax_income_estimate": [ -143.26, -162.29, -171.86, -120.45, 1.15 ], "operating_cash_flow_per_share_estimate": [ -0.28, -0.31, -0.26, -0.37, -0.33 ], "roa_estimate": [ -65.2, -68.2, -71.6, -87.7, -75.1 ], "roe_estimate": [ -73.45, -88.05, -108.85, -102.75, -117.95 ], "gross_margin_estimate": [ 60, 60, 78, 73.2, 85.43 ], "operating_cash_flow_estimate": [ -100.08, -110.8, -91.14, -132.25, -116.16 ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": 8.77, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 44.55, "future_eps_nri_estimate_growth": 8.77, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -14.86, "future_ebitda_estimate_growth": 32.62, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -10.47, "future_pretax_income_estimate_growth": 32.37, "future_book_value_per_share_estimate_growth": -14.93, "future_roa_estimate_growth": 34.11, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": 14.8 }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 0.01, 0.01, 0.2, null, null, null, 0.23 ], "ebit_estimate": [ -36.93, -40.14, -42.97, -41.29, -42.35, -43.77, -44.33 ], "ebitda_estimate": [ -34.2, -36.47, -38.47, null, null, null, null ], "net_income_estimate": [ -34.23, -37.37, -39.74, -41.86, -42.93, -44.3, -44.57 ], "per_share_eps_estimate": [ -0.11, -0.11, -0.12, -0.1, -0.11, -0.11, -0.11 ], "eps_nri_estimate": [ -0.1, -0.1, -0.11, -0.09, -0.1, -0.1, -0.1 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ 0.48, 0.42, 0.61, 0.55, 0.48, 0.4, 0.32 ], "pretax_income_estimate": [ -34.71, -37.64, -40.84, -41.86, -42.93, -44.33, -44.57 ], "operating_cash_flow_per_share_estimate": [ -0.06, -0.06, -0.06, -0.06, -0.07, -0.07, -0.08 ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ 50, 50, 50, 70, 70, 70, 70 ], "operating_cash_flow_estimate": [ -21.45, -21.45, -21.45, -21.45, -25.02, -25.02, -28.59 ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": 8.77, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 44.55, "future_eps_nri_estimate_growth": 8.77, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": -14.86, "future_ebitda_estimate_growth": 32.62, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -10.47, "future_pretax_income_estimate_growth": 32.37, "future_book_value_per_share_estimate_growth": -14.93, "future_roa_estimate_growth": 34.11, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": 14.8 }

News

2026-07-07 12:40:00
2026-07-06 16:09:03
2026-07-06 15:59:18
2026-07-06 14:25:30
2026-06-25 10:28:19